0
Signin
countryflagCA

888-969-2592

RY 151.2 -0.6636% TD 80.12 0.9577% SHOP 83.0 1.3802% CNR 158.42 -0.9751% ENB 50.51 0.0198% CP 113.01 0.9108% BMO 119.55 0.3357% TRI 227.18 0.6334% CNQ 47.185 -0.851% BN 64.45 1.7524% ATD 82.17 -0.8208% CSU 4335.0 0.7153% BNS 62.975 -0.3402% CM 69.78 0.7508% SU 53.02 0.9136% TRP 57.81 1.1018% NGT 63.51 -3.5535% WCN 241.16 -2.9029% MFC 35.73 0.7614% BCE 45.805 0.0546%

Entourage Health Corp

Healthcare CA ENTG

0.015CAD
0.005(50.00%)

Last update at 2024-07-25T13:30:00Z

Day Range

0.010.01
LowHigh

52 Week Range

0.010.03
LowHigh

Fundamentals

  • Previous Close 0.01
  • Market Cap4.63M
  • Volume1100
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA-30.28242M
  • Revenue TTM39.46M
  • Revenue Per Share TTM0.13
  • Gross Profit TTM -11.71492M
  • Diluted EPS TTM-0.37

Analyst Recommendations

Financials

Income Statement

Balancesheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Income before tax -123.14645M -78.93513M -89.60713M -10.39236M -0.89513M
Minority interest - - - - -
Net income -123.14645M -78.93513M -89.60713M -10.39236M -0.89513M
Selling general administrative 29.64M 29.19M 28.48M 21.06M 14.92M
Selling and marketing expenses - - - - -
Gross profit -19.89095M -11.71492M -24.20558M 14.87M 4.63M
Reconciled depreciation 5.85M 6.75M 2.15M 0.28M 0.10M
Ebit -51.50768M -44.04052M -56.63934M -8.36338M -10.53252M
Ebitda -100.10442M -61.40768M -81.54709M -8.87079M -0.34866M
Depreciation and amortization - - - - -
Non operating income net other - - - - -
Operating income -52.02949M -41.73867M -51.45956M -6.50873M -10.33683M
Other operating expenses - - - - -
Interest expense 17.19M 10.77M 5.91M 1.24M 0.44M
Tax provision 0.00000M - - - 0.00000M
Interest income - 0.00000M 0.07M 0.22M 0.51M
Net interest income -17.46158M -10.89015M -5.84092M -1.01985M 0.07M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense - - - - -
Total revenue 40.89M 42.27M 29.43M 20.82M 7.96M
Total operating expenses 92.92M 84.01M 80.89M 27.33M 18.29M
Cost of revenue 60.78M 53.99M 53.64M 5.95M 3.32M
Total other income expense net -53.65538M -26.30632M -32.30666M -2.86378M 9.37M
Discontinued operations - - - - -
Net income from continuing ops -123.14645M -78.93513M -89.60713M -10.39236M -0.89513M
Net income applicable to common shares - -78.93513M -89.60713M -10.39236M -0.89513M
Preferred stock and other adjustments - - - - -
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Total assets 46.47M 144.22M 171.33M 209.80M 88.07M
Intangible assets - - 4.50M 21.00M -
Earning assets - - - - -
Other current assets - 0.71M 8.10M 10.78M 2.77M
Total liab 147.71M 122.80M 97.24M 73.74M 10.98M
Total stockholder equity -101.23893M 21.43M 74.09M 136.06M 77.09M
Deferred long term liab - - - - -
Other current liab - - 0.80M 2.69M 0.12M
Common stock - 185.81M 163.23M 137.65M 79.69M
Capital stock 186.14M 185.81M 163.23M 137.65M 79.69M
Retained earnings -319.36802M -196.22157M -117.28644M -27.67931M -17.28695M
Other liab - - - 0.13M -
Good will - - - 16.12M -
Other assets - 1.10M 0.49M 0.82M 5.89M
Cash 9.08M 21.42M 22.32M 8.18M 21.22M
Cash and equivalents - - - - -
Total current liabilities 141.88M 116.39M 21.73M 29.15M 10.98M
Current deferred revenue - - - - -
Net debt 124.50M 81.00M 55.98M 35.97M -
Short term debt - - - - -
Short long term debt 128.42M 97.85M 3.99M 1.87M -
Short long term debt total - - - - -
Other stockholder equity - 14.97M 12.11M 12.11M 8.07M
Property plant equipment - 81.70M 100.04M 112.09M 40.99M
Total current assets 40.09M 61.43M 66.30M 59.77M 40.82M
Long term investments - - - - -
Net tangible assets - 21.43M 69.59M 98.94M 76.72M
Short term investments - 0.00000M 0.23M 0.44M 1.59M
Net receivables 3.79M 8.73M 4.20M 6.13M 7.81M
Long term debt 5.15M 4.57M 74.32M 42.28M -
Inventory 14.78M 29.64M 30.67M 31.29M 5.83M
Accounts payable 2.67M 5.12M 7.62M 23.13M 10.85M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income - - - - -
Additional paid in capital - - - - -
Common stock total equity - - - - -
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other - - - - -
Deferred long term asset charges - - - - -
Non current assets total 6.38M 82.84M 104.54M 150.03M 47.25M
Capital lease obligations 0.96M 2.94M 2.57M 3.65M -
Long term debt total - - - - -
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Investments -1.31695M 1.84M 0.14M 0.52M -1.27058M
Change to liabilities - 0.00000M 0.00000M 14.60M -0.24061M
Total cashflows from investing activities - 1.84M -1.40091M -48.95982M -28.92060M
Net borrowings - 11.10M 29.26M 47.47M 47.47M
Total cash from financing activities 21.14M 24.06M 51.26M 46.09M 34.99M
Change to operating activities - -18.21809M -27.24731M 4.92M 1.44M
Net income -123.14645M -78.93513M -89.60713M -10.39236M -0.89513M
Change in cash -10.34082M -4.10201M 14.32M -10.02725M -3.37151M
Begin period cash flow 21.52M 25.62M 11.30M 21.32M 24.70M
End period cash flow 11.18M 21.52M 25.62M 11.30M 21.32M
Total cash from operating activities -30.16639M -30.00708M -35.53871M -7.16061M -9.44125M
Issuance of capital stock 0.00000M 15.58M 25.00M 0.00000M 32.22M
Depreciation 5.85M 6.75M 7.00M 1.11M 0.10M
Other cashflows from investing activities - - - -2.23726M 8.83M
Dividends paid 0.00000M 0.00000M 0.00000M 0.00000M 0.00000M
Change to inventory -8.23312M -11.45952M 11.98M -13.99278M -2.94118M
Change to account receivables 3.65M -4.57638M 1.09M -1.31245M -2.07000M
Sale purchase of stock - - - - -
Other cashflows from financing activities - -2.87139M -3.00145M -1.91311M 2.38M
Change to netincome - 60.39M 74.31M -2.09030M -4.83574M
Capital expenditures 1.70M 0.45M 1.18M 55.29M 36.48M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital -10.42004M -18.21809M 4.87M 4.21M -3.81472M
Stock based compensation 0.48M 0.86M 2.64M 4.76M -
Other non cash items 27.36M 18.92M 8.12M -8.86949M -1.38076M
Free cash flow -31.86335M -30.50995M -37.07883M -63.65332M -37.09126M

Peer Comparison

Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic

Company Change (CAD) Price (CAD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
ENTG
Entourage Health Corp		 0.005 50.00% 0.01 - - 0.12 2.69 3.81 -1.6005
RX
Biosyent Inc.		 -0.19 1.88% 9.91 16.47 16.26 3.21 2.88 2.32 8.03
LOVE
Cannara Biotech Inc		 -0.04 6.67% 0.56 10.00 - 1.26 0.90 1.98 7.20
DB
Decibel Cannabis Company Inc		 - -% 0.06 - 3.38 0.48 1.17 0.87 39.48
LSL
LSL Pharma Group Inc.		 -0.005 1.04% 0.47 - - 4.65 4.23 6.13 -14.2493

Reports Covered

Stock Research & News

View All

Profile

Entourage Health Corp. engages in the production and distribution of cannabis products for medical and adult-use markets in Canada. It offers cannabis plants, dried flower, pre-rolls, soft chews, chewing gum, cannabis oils, capsules, topicals and vapes, extracts, and edibles. The company sells its products under the Color Cannabis, Saturday Cannabis, Starseed Medicinal, Syndicate Cannabis, Mary's Medicinals, and Irwin Naturals brand names. The company was formerly known as WeedMD Inc. and changed its name to Entourage Health Corp. in July 2021. Entourage Health Corp. is headquartered in Aylmer, Canada.

Entourage Health Corp

276 Queen Street West, Toronto, ON, Canada, M5V 2A1

Key Executives

Name Title Year Born
Mr. George Scorsis Exec. Chair & CEO 1976
Ms. Deborah Sikkema Chief People Officer NA
Mr. Jeff Keyes Sr. VP of Operations NA
Mr. Joseph Mele Chief Commercial Officer NA
Ms. Vaani Maharaj Chief Financial Officer NA
Mr. James Afara Chief Operating Officer NA
Dr. Alexandre Sibilev Vice-Pres of Quality Assurance & Global Regulatory Compliance NA
Ms. Marianella delaBarrera Sr. VP of Communications & Corp. Affairs NA
Mr. Michael P. Kraft Strategic Advisor to the board 1963
Dr. Jonas Vanderzwan Medical Director & Chair of Clinical Advisory Board NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.